Cơ Chế Tác Dụng :
751689 is orally-active calcilytics.
751689 is novel small molecules that work by antagonizing calcium-sensing receptors on the surface of the parathyroid gland, thereby triggering a transient release of the body's own stores of parathyroid hormone (PTH). This release of PTH may have the potential to rebuild the bone mass lost as a result of osteoporosis and improve overall bone microarchitecture in these patients.
Chỉ Định :
Post-menopausal women with osteoporosis